President Donald Trump's pick to be the next U.S. surgeon general has repeatedly said the nation's medical, health, and food ...

Research suggests women with high breast cancer risk and menopausal symptoms could benefit from Duavee, which reduced breast ...

The Trump administration is eroding national pandemic flu defenses as it guts health agencies, cuts research and health ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at ...

Pfizer Inc. closed 26.70% short of its 52-week high of $31.54, which the company achieved on July 30th.

Arvinas and Pfizer have filed for U.S. Food and Drug Administration approval of their proposed breast-cancer drug vepdegestrant in certain patients with estrogen-receptor mutations.

A new partnership between Hartford HealthCare and Pfizer is taking aim at migraines in the workplace. The innovative program ...

Hundreds of women allege Pfizer's contraceptive injection caused tumors, accusing the company of ignoring known dangers and ...

Patent claims reciting compounds where at least one group of a compound genus is defined by its function are common. For ...

COVID India (June 6) : 5,364 active cases; 4 new deaths in a day, Kerala reports highest coronavirus cases Kerala has ...